<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00410930</url>
  </required_header>
  <id_info>
    <org_study_id>DV08.01</org_study_id>
    <nct_id>NCT00410930</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients</brief_title>
  <official_title>Double-Blind Placebo-Controlled Study of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stallergenes Greer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stallergenes Greer</source>
  <brief_summary>
    <textblock>
      To compare versus placebo the efficacy and safety of recombinant Bet v1, natural purified Bet&#xD;
      v1 and birch pollen licenced extract used for subcutaneous immunotherapy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>November 2002</start_date>
  <completion_date>November 2005</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of symptom and medication scores.</measure>
  </primary_outcome>
  <enrollment>160</enrollment>
  <condition>Allergy</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Subcutaneous immunotherapy - Recombinant birch pollen</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 18-50 with seasonal rhinoconjunctivitis for at least 2 years, and/or&#xD;
             mild asthma range 1 and 2 GINA.&#xD;
&#xD;
          -  Positive history of birch pollen allergy (clinical history, positive skin prick test,&#xD;
             birch specific IgE, presence of birch pollen)&#xD;
&#xD;
          -  Compliant patients&#xD;
&#xD;
          -  Written consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Perennial rhinoconjunctivitis and/or asthma due to cosensitization with: animal&#xD;
             danders, mites, alternaria cladosporium&#xD;
&#xD;
          -  Uncontrolled seasonal asthma : severe asthma permanent or not range 3 and 4 of GINA.&#xD;
&#xD;
          -  Patients treated with beta-blockers or under continuous oral corticosteroids.&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabrielle PAULI, MD, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>HÃ´pital Liautey - Strasbourg, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pr Gabrielle PAULI</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2006</verification_date>
  <study_first_submitted>December 12, 2006</study_first_submitted>
  <study_first_submitted_qc>December 12, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2006</study_first_posted>
  <last_update_submitted>December 15, 2006</last_update_submitted>
  <last_update_submitted_qc>December 15, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2006</last_update_posted>
  <keyword>Immunotherapy, major allergen, birch</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

